Skip to main content

Treatment Clinical Trials for Ewing Sarcoma

Review the Ewing sarcoma treatment clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-14 of 14

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Status: Active
Location: 12 locations
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Status: Active
Location: 11 locations
Cabozantinib to Prevent Progression or Recurrence in Patients with High-Risk Pediatric Solid Tumors
Status: Active
Location: 6 locations
Sirolimus and Metronomic Chemotherapy for the Treatment of High-Risk Solid Tumors in Children, AflacST1903 Study
Status: Active
Location: 6 locations
Donor Bone Marrow Transplant in Treating Patients with High-Risk Solid Tumors
Status: Active
Location: 4 locations
Altering the Selection and Timing of Therapies for the Treatment of Widely Metastatic Ewing Sarcoma and CIC-Rearranged Sarcoma
Status: Active
Location: 4 locations
Lurbinectedin for the Treatment of Patients with Relapsed FET-Fused Tumors
Status: Active
Location: 4 locations
Genetically Modified Donor Stem Cell Transplant Followed by Zoledronic Acid in Treating Younger Patients with Relapsed/Refractory Hematologic Malignancies or High Risk Solid Tumors
Status: Active
Location: 2 locations
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
Status: Active
Location: 2 locations
Hypofractionated Radiation and Lymphodepleting Chemotherapy Followed by B7-H3-CAR T Cells for the Treatment of Pediatric Patients with Relapsed or Refractory Sarcomas
Status: Active
Location: Saint Jude Children's Research Hospital, Memphis, Tennessee
Tumor Infiltrating Lymphocytes for the Treatment of Children with High Risk Solid Tumors
Status: Active
Location: Johns Hopkins All Children's Hospital, Saint Petersburg, Florida
Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
PM14 Administered Intravenously to Patients with Advanced Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
A Study of EGFR806 CAR T-Cell Immunotherapy for Treating Children and Young Adults with Recurrent/Refractory Solid Tumors
Status: Temporarily Closed to Accrual
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington